| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cogent Biosciences, Inc. (COGT) has 8 insiders with recent SEC Form 4 filings, including 3 buys and 0 sells. COGT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 12.50M | $431.87M | - | |
| CEO | 245.0K | $8.46M | - | |
| Other | 216.7K | $7.48M | - | |
| Other | 140.0K | $4.84M | - | |
| Other | 133.9K | $4.63M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2018 | Atlas Venture Fund Ix, L.P. | 10% Owner | Buy | 94,052 | $12.00 | $1,128,624.00 | +2.9% | |
| Apr 3, 2018 | Ratcliffe Liam86 | Director | Buy | 550,000 | $12.00 | $6,600,000.00 | +44.2% |